Previous Section Index Home Page


5 Mar 2004 : Column 1173W—continued

Cancer Treatment

Mrs. Calton: To ask the Secretary of State for Health (1) what plans he has to publish information on waiting times for treatment of cancers not covered by NHS Cancer Plan targets before 2005; [157771]

Miss Melanie Johnson: The primary purpose of the NHS Cancer Plan is to save more lives. Reducing waiting times is key to achieving this. The ultimate goal in the NHS Cancer Plan is to offer patients a maximum one month wait from an urgent referral for suspected cancer to the beginning of treatment. Where patients wait longer, this should be because of the needs of the diagnostic process or their personal choice, not because of in-built delays in the system of care. We hope to achieve this goal by 2008.

Current waiting times targets are milestones towards this. Data on achievement of current targets from urgent general practitioner referral to treatment for acute leukaemia, children's and testicular cancers and breast cancer and from diagnosis to treatment for breast cancer, are published quarterly on the Department's website for strategic health authorities and trusts, at: http://www.performance.doh.gov.uk/cancerwaits. Data on achievement of future cancer plan waiting times targets

5 Mar 2004 : Column 1174W

of one month from diagnosis to treatment and two months from urgent general practitioner referral to treatment for all cancers will be published once these targets have been implemented in 2005.

Mrs. Calton: To ask the Secretary of State for Health what assessment his Department has made of the incidence of melanoma by (a) age group and (b) strategic health authority. [157800]

Ruth Kelly: I have been asked to reply.

The information requested falls within the responsibility of the National Statistician, who has been asked to reply.

Letter from John Pullinger to Mrs. Calton, dated 5 March 2004:



Directly age standardised(2) rates per 100,000 population of newly diagnosed cases of malignant melanoma of the skin(3) in England, by strategic health authority, 2000

Strategic health authorityMalesFemales
England9.711.2
Norfolk, Suffolk and Cambridgeshire10.811.4
Bedfordshire and Hertfordshire9.310.0
Essex9.613.5
North West London6.65.5
North Central London15.115.1
North East London7.24.4
South East London8.38.8
South West London10.012.7
Northumberland, Tyne and Wear6.48.9
County Durham and Tees Valley9.310.9
North and East Yorkshire and Northern Lincolnshire4.37.2
West Yorkshire7.89.5
Cumbria and Lancashire11.311.2
Greater Manchester8.111.0
Cheshire and Merseyside7.513.9
Thames Valley14.817.1
Hampshire and Isle of Wight12.215.7
Kent and Medway8.47.8
Surrey and Sussex10.013.8
Avon, Gloucestershire and Wiltshire11.713.1
South West Peninsula17.715.8
Dorset and Somerset15.217.2
South Yorkshire6.98.3
Trent8.69.5
Leicestershire, Northamptonshire and Rutland9.911.3
Shropshire and Staffordshire7.09.3
Birmingham and the Black Country7.58.7
Coventry, Warwickshire, Herefordshire and Worcestershire11.110.3

(2) Using the European standard population

(3) International Classification of Diseases, Tenth Revision (ICD-10) code C43.

Source:

Office for National Statistics


5 Mar 2004 : Column 1175W

Capital Projects

Mr. Luff: To ask the Secretary of State for Health (1) for what reasons he imposed a retrospective cut-off date for approvals for local capital projects proposed by primary care trusts; [157962]

Mr. Hutton: Significant new revenue funding will be made available to support public and private capital investment in the primary care estate, based on local prioritisation of development proposals. Baseline allocations for 2004–05 have been notified to all primary care trusts, and these take account of new developments contractually agreed by 30 September 2003. This date was set to allow sufficient time for robust baselines to be established and notified to PCTs. An additional element of growth funding to support prioritised developments contractually agreed after that date will be allocated to lead-PCTs.

We are not aware that any schemes have been cancelled at this time.

Chiropody Statistics

Mr. Burstow: To ask the Secretary of State for Health if he will set out for (a) England and (b) each strategic health authority the KT23 statistics for each year since 1996. [144757]

Dr. Ladyman: The available information is published in NHS Chiropody Services, Summary Information for 2002–03, England and is available in the Library and at http://www.doh.gov.uk/public/kt230203. The tables show England figures for 1996–97 to 2002–03 and strategic health authority (SHA) figures for 2002–03; SHAs came into existence in April 2002 and comparable data for earlier years are not readily available due to service reconfigurations.

Chiropody contacts, England, 1996–97 to 2002–03
England   Thousand

Initial contacts (new episodesof care)First contacts (different persons receiving care)Total face-to-face contacts(4)
1996–979662,4478,352
1997–989272,4198,305
1998–998782,3628,054
1999–20008532,3177,895
2000–018372,264
2001–028372,216
2002–038262,161

(4) The collection of data about total face-to-face contacts was discontinued from 1 April 2000

Source:

Form KT23


5 Mar 2004 : Column 1176W

Chiropody contacts by strategic health authority, 2002–03
Thousand

Strategic health authorityInitial contacts (new episodes of care)First contacts (different persons receiving care)
County Durham and Tees Valley15.851.7
Northumberland, Tyne and Wear22.779.7
Cheshire and Merseyside51.6117.9
Cumbria and Lancashire35.7110.5
Greater Manchester59.1172.8
North and East Yorkshire and Northern Lincolnshire23.483.1
South Yorkshire24.677.2
West Yorkshire33.8126.9
Leicestershire, Northamptonshire and Rutland33.853.1
Trent43.9112.8
Birmingham and the Black Country62.2125.3
Coventry, Warwickshire, Hereford and Worcesters21.172.5
Shropshire and Staffordshire22.782.4
Bedfordshire and Hertfordshire15.349.1
Essex14.442.3
Norfolk, Suffolk and Cambridgeshire27.481.4
North Central London17.243.1
North East London27.446.9
North West London22.464.7
South East London34.961.1
South West London17.150.4
Hampshire and Isle of Wight22.148.4
Kent and Medway23.358.7
Surrey and Sussex30.884.0
Thames Valley23.956.2
Avon, Gloucestershire and Wiltshire41.789.0
Dorset and Somerset23.638.8
South West Peninsula34.181.5

Source:

Form KT23


Cholesterol

Mr. Paul Burstow: To ask the Secretary of State for Health if he will estimate the prevalence of raised blood cholesterol in (a) men and (b) women in each region; and if he will make a statement. [154583]

Miss Melanie Johnson: Figures available from the Health Survey for England 1998 are shown in the table. In this survey, cholesterol was considered to be raised at a level of 6.5 mmol/l or over.

Prevalence of raised cholesterol by Government Office Region and sex—Adults 16+ with a valid sample
Raised cholesterol (percentage >=6.5 mmol/l)   1998

Government OfficeRegionsMen (percentage)Women (percentage)Men (bases)Women (bases)
North East27.128.5288337
North West16.920.7669720
Yorkshire and the Humber17.922.5531591
West Midlands20.323.8492589
East Midlands14.821.7453483
East England16.221.8537577
London16.717.4527614
South East19.624.2810945
South West16.522.4539572

Source:

Health Survey for England , Department of Health


5 Mar 2004 : Column 1177W

The quality indicators for the new general medical services contract include cholesterol management for patients with coronary heart disease. This will reinforce general practitioners' current work to deliver the quality standards set out in the national service framework for coronary heart disease, which are driving the present trend in increasing statin prescriptions.


Next Section Index Home Page